
The Diabetes Drug That Could Save Your HEART
The FDA has approved Mounjaro for cardiovascular risk reduction in people with type 2 diabetes. Milko · E+/Getty The FDA has approved Mounjaro to help reduce the risk of major cardiovascular events in people with type 2 diabetes who are at high risk. A major clinical trial found that Mounjaro performed as well as Trulicity for reducing the risk of heart attack, stroke, and cardiovascular death. People taking Mounjaro had an 8% lower relative risk of major cardiovascular events compared with


























































.gif)






























































































































































































































































































